Federico Grossi - 15 Nov 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Issuer symbol
APLS
Transactions as of
15 Nov 2021
Net transactions value
-$27,188
Form type
4
Filing time
17 Nov 2021, 16:02:44 UTC
Previous filing
02 Nov 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $27,188 -625 -0.96% $43.50 64,479 15 Nov 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled sale from 10B5-1 trading plan.
F2 This includes 299 shares from 10/29/2021 ESPP Purchase.